{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:04:51Z","timestamp":1780628691383,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S16","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12859-017-1957-5","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T08:29:38Z","timestamp":1514449778000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection"],"prefix":"10.1186","volume":"18","author":[{"given":"Nikhil","family":"Pathak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ling","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty-Wu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guann-Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinn-Moon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"issue":"3","key":"1957_CR1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1358\/dot.2012.48.3.1740457","volume":"48","author":"R Talwani","year":"2012","unstructured":"Talwani R, Gilliam BL, Rizza SA, Nehra V, Temesgen Z. Current status of treatment for chronic hepatitis C virus infection. Drugs Today (Barc). 2012;48(3):219\u201331.","journal-title":"Drugs Today (Barc)"},{"issue":"1","key":"1957_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","volume":"6","author":"X Zhang","year":"2016","unstructured":"Zhang X. Direct anti-HCV agents. Acta Pharm Sin B. 2016;6(1):26\u201331.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"1957_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrgastro.2014.198","volume":"12","author":"P Ferenci","year":"2015","unstructured":"Ferenci P. Viral hepatitis: cure of chronic hepatitis C--required length of follow-up? Nat Rev Gastroenterol Hepatol. 2015;12(1):10\u20131.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"15","key":"1957_CR4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4254\/wjh.v7.i15.1953","volume":"7","author":"EG Hilgenfeldt","year":"2015","unstructured":"Hilgenfeldt EG, Schlachterman A, Firpi RJ. Hepatitis C: treatment of difficult to treat patients. World J Hepatol. 2015;7(15):1953\u201363.","journal-title":"World J Hepatol"},{"issue":"1","key":"1957_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCC.0b013e3181e911a7","volume":"12","author":"S Ranjit","year":"2011","unstructured":"Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med. 2011;12(1):90\u2013100.","journal-title":"Pediatr Crit Care Med"},{"issue":"7446","key":"1957_CR6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504\u20137.","journal-title":"Nature"},{"issue":"5","key":"1957_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/bpa.12280","volume":"25","author":"BK Kleinschmidt-DeMasters","year":"2015","unstructured":"Kleinschmidt-DeMasters BK, Beckham JD. West Nile virus encephalitis 16 years later. Brain Pathol. 2015;25(5):625\u201333.","journal-title":"Brain Pathol"},{"issue":"10","key":"1957_CR8","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1517\/14728222.2015.1065817","volume":"19","author":"T Ishikawa","year":"2015","unstructured":"Ishikawa T, Konishi E. Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges. Expert Opin Ther Targets. 2015;19(10):1379\u201395.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"1957_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5694\/mja11.11026","volume":"196","author":"J Knox","year":"2012","unstructured":"Knox J, Cowan RU, Doyle JS, Ligtermoet MK, Archer JS, Burrow JN, Tong SY, Currie BJ, Mackenzie JS, Smith DW, et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust. 2012;196(5):322\u20136.","journal-title":"Med J Aust"},{"key":"1957_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2014.12.010","volume":"115","author":"DW Beasley","year":"2015","unstructured":"Beasley DW, McAuley AJ, Bente DA. Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy. Antivir Res. 2015;115:48\u201370.","journal-title":"Antivir Res"},{"issue":"4","key":"1957_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.JAA.0000481413.11539.b1","volume":"29","author":"RA Borchardt","year":"2016","unstructured":"Borchardt RA. Zika virus: a rapidly emerging infectious disease. JAAPA. 2016;29(4):48\u201350.","journal-title":"JAAPA"},{"issue":"330","key":"1957_CR12","doi-asserted-by":"crossref","first-page":"330ed332","DOI":"10.1126\/scitranslmed.aaf4548","volume":"8","author":"GJ Nabel","year":"2016","unstructured":"Nabel GJ, Zerhouni EA. Once and future epidemics: Zika virus emerging. Sci Transl Med. 2016;8(330):330ed332.","journal-title":"Sci Transl Med"},{"issue":"5","key":"1957_CR13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/imj.13059","volume":"46","author":"CW Ong","year":"2016","unstructured":"Ong CW. Zika virus: an emerging infectious threat. Intern Med J. 2016;46(5):525\u201330.","journal-title":"Intern Med J"},{"key":"1957_CR14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0470058005.ch2","volume":"277","author":"DJ Gubler","year":"2006","unstructured":"Gubler DJ. Dengue\/dengue haemorrhagic fever: history and current status. Novartis Found Symp. 2006;277:3\u201316. discussion 16-22, 71-13, 251-253","journal-title":"Novartis Found Symp"},{"key":"1957_CR15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12985-015-0444-8","volume":"12","author":"T Nedjadi","year":"2015","unstructured":"Nedjadi T, El-Kafrawy S, Sohrab SS, Despres P, Damanhouri G, Azhar E. Tackling dengue fever: current status and challenges. Virol J. 2015;12:212.","journal-title":"Virol J"},{"issue":"2","key":"1957_CR16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","volume":"100","author":"SP Lim","year":"2013","unstructured":"Lim SP, Wang QY, Noble CG, Chen YL, Dong H, Zou B, Yokokawa F, Nilar S, Smith P, Beer D, et al. Ten years of dengue drug discovery: progress and prospects. Antivir Res. 2013;100(2):500\u201319.","journal-title":"Antivir Res"},{"issue":"2","key":"1957_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","volume":"87","author":"M Bollati","year":"2010","unstructured":"Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, Coutard B, Decroly E, de Lamballerie X, Gould EA, et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antivir Res. 2010;87(2):125\u201348.","journal-title":"Antivir Res"},{"issue":"6","key":"1957_CR18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12250-013-3390-x","volume":"28","author":"M Brecher","year":"2013","unstructured":"Brecher M, Zhang J, Li H. The flavivirus protease as a target for drug discovery. Virol Sin. 2013;28(6):326\u201336.","journal-title":"Virol Sin"},{"key":"1957_CR19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","volume":"118","author":"D Luo","year":"2015","unstructured":"Luo D, Vasudevan SG, Lescar J. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antivir Res. 2015;118:148\u201358.","journal-title":"Antivir Res"},{"issue":"1","key":"1957_CR20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","volume":"81","author":"A Sampath","year":"2009","unstructured":"Sampath A, Padmanabhan R. Molecular targets for flavivirus drug discovery. Antivir Res. 2009;81(1):6\u201315.","journal-title":"Antivir Res"},{"issue":"2","key":"1957_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4155\/fmc.09.27","volume":"1","author":"BJ Geiss","year":"2009","unstructured":"Geiss BJ, Stahla H, Hannah AM, Gari AM, Keenan SM. Focus on flaviviruses: current and future drug targets. Future Med Chem. 2009;1(2):327\u201344.","journal-title":"Future Med Chem"},{"issue":"5","key":"1957_CR22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2217\/fvl.10.39","volume":"5","author":"SA Shiryaev","year":"2010","unstructured":"Shiryaev SA, Strongin AY. Structural and functional parameters of the flaviviral protease: a promising antiviral drug target. Future Virol. 2010;5(5):593\u2013606.","journal-title":"Future Virol"},{"issue":"21","key":"1957_CR23","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.2174\/13816128113199990633","volume":"20","author":"A Poulsen","year":"2014","unstructured":"Poulsen A, Kang C, Keller TH. Drug design for flavivirus proteases: what are we missing? Curr Pharm Des. 2014;20(21):3422\u20137.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1957_CR24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2009.02.190","volume":"82","author":"SM Tomlinson","year":"2009","unstructured":"Tomlinson SM, Malmstrom RD, Russo A, Mueller N, Pang YP, Watowich SJ. Structure-based discovery of dengue virus protease inhibitors. Antivir Res. 2009;82(3):110\u20134.","journal-title":"Antivir Res"},{"key":"1957_CR25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2015.12.030","volume":"110","author":"M Cabarcas-Montalvo","year":"2016","unstructured":"Cabarcas-Montalvo M, Maldonado-Rojas W, Montes-Grajales D, Bertel-Sevilla A, Wagner-Dobler I, Sztajer H, Reck M, Flechas-Alarcon M, Ocazionez R, Olivero-Verbel J. Discovery of antiviral molecules for dengue: in silico search and biological evaluation. Eur J Med Chem. 2016;110:87\u201397.","journal-title":"Eur J Med Chem"},{"key":"1957_CR26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12879-016-1668-y","volume":"16","author":"CR Vicente","year":"2016","unstructured":"Vicente CR, Herbinger KH, Froschl G, Malta Romano C, de Souza Areias Cabidelle A, Cerutti Junior C. Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitoria, Brazil. BMC Infect Dis. 2016;16:320.","journal-title":"BMC Infect Dis"},{"issue":"49","key":"1957_CR27","doi-asserted-by":"crossref","first-page":"20986","DOI":"10.1073\/pnas.1006370107","volume":"107","author":"KP Romano","year":"2010","unstructured":"Romano KP, Ali A, Royer WE, Schiffer CA. Drug resistance against HCV NS3\/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding. Proc Natl Acad Sci U S A. 2010;107(49):20986\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Web Server issu","key":"1957_CR28","doi-asserted-by":"crossref","first-page":"W424","DOI":"10.1093\/nar\/gkq480","volume":"38","author":"YF Chen","year":"2010","unstructured":"Chen YF, Hsu KC, Lin SR, Wang WC, Huang YC, Yang JM. SiMMap: a web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties. Nucleic Acids Res. 2010;38(Web Server issue):W424\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1957_CR29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/prot.20035","volume":"55","author":"JM Yang","year":"2004","unstructured":"Yang JM, Chen CC. GEMDOCK: a generic evolutionary method for molecular docking. Proteins. 2004;55(2):288\u2013304.","journal-title":"Proteins"},{"issue":"Suppl 1","key":"1957_CR30","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","volume":"12","author":"KC Hsu","year":"2011","unstructured":"Hsu KC, Chen YF, Lin SR, Yang JM. iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinformatics. 2011;12(Suppl 1):S33.","journal-title":"BMC Bioinformatics"},{"issue":"7104","key":"1957_CR31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nature04975","volume":"442","author":"IC Lorenz","year":"2006","unstructured":"Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM. Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature. 2006;442(7104):831\u20135.","journal-title":"Nature"},{"issue":"1","key":"1957_CR32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","volume":"86","author":"CG Noble","year":"2012","unstructured":"Noble CG, Seh CC, Chao AT, Shi PY. Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol. 2012;86(1):438\u201346.","journal-title":"J Virol"},{"issue":"2","key":"1957_CR33","doi-asserted-by":"crossref","first-page":"e32142","DOI":"10.1371\/journal.pone.0032142","volume":"7","author":"KC Hsu","year":"2012","unstructured":"Hsu KC, Cheng WC, Chen YF, Wang HJ, Li LT, Wang WC, Yang JM. Core site-moiety maps reveal inhibitors and binding mechanisms of orthologous proteins by screening compound libraries. PLoS One. 2012;7(2):e32142.","journal-title":"PLoS One"},{"issue":"7","key":"1957_CR34","doi-asserted-by":"crossref","first-page":"e1003127","DOI":"10.1371\/journal.pcbi.1003127","volume":"9","author":"KC Hsu","year":"2013","unstructured":"Hsu KC, Cheng WC, Chen YF, Wang WC, Yang JM. Pathway-based screening strategy for multitarget inhibitors of diverse proteins in metabolic pathways. PLoS Comput Biol. 2013;9(7):e1003127.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"1957_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2040622312441496","volume":"3","author":"A Ascione","year":"2012","unstructured":"Ascione A. Boceprevir in chronic hepatitis C infection: a perspective review. Ther Adv Chronic Dis. 2012;3(3):113\u201321.","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"1957_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cld.2012.09.010","volume":"17","author":"AB Jesudian","year":"2013","unstructured":"Jesudian AB, Jacobson IM. Telaprevir for chronic hepatitis C virus infection. Clin Liver Dis. 2013;17(1):47\u201362.","journal-title":"Clin Liver Dis"},{"key":"1957_CR37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2147\/TCRM.S66731","volume":"10","author":"I Gentile","year":"2014","unstructured":"Gentile I, Buonomo AR, Zappulo E, Minei G, Morisco F, Borrelli F, Coppola N, Borgia G. Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. Ther Clin Risk Manag. 2014;10:493\u2013504.","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"1957_CR38","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1021\/cb5006118","volume":"9","author":"DI Soumana","year":"2014","unstructured":"Soumana DI, Ali A, Schiffer CA. Structural analysis of asunaprevir resistance in HCV NS3\/4A protease. ACS Chem Biol. 2014;9(11):2485\u201390.","journal-title":"ACS Chem Biol"},{"issue":"4","key":"1957_CR39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","volume":"13","author":"P Erbel","year":"2006","unstructured":"Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol. 2006;13(4):372\u20133.","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"1957_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nmeth.3211","volume":"12","author":"T Weinert","year":"2015","unstructured":"Weinert T, Olieric V, Waltersperger S, Panepucci E, Chen L, Zhang H, Zhou D, Rose J, Ebihara A, Kuramitsu S, et al. Fast native-SAD phasing for routine macromolecular structure determination. Nat Methods. 2015;12(2):131\u20133.","journal-title":"Nat Methods"},{"issue":"7","key":"1957_CR41","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG. ZINC: a free tool to discover chemistry for biology. J Chem Inf Model. 2012;52(7):1757\u201368.","journal-title":"J Chem Inf Model"},{"issue":"Database issue","key":"1957_CR42","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu T, Lin Y, Wen X, Jorissen RN, Gilson MK. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 2007;35(Database issue):D198\u2013201.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1957_CR43","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/protein\/11.9.739","volume":"11","author":"IN Shindyalov","year":"1998","unstructured":"Shindyalov IN, Bourne PE. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng. 1998;11(9):739\u201347.","journal-title":"Protein Eng"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-017-1957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T19:57:07Z","timestamp":1570564627000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-017-1957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":43,"journal-issue":{"issue":"S16","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1186\/s12859-017-1957-5","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"548"}}